Oriola Oyj — Financial Supplement Data 2025

Apr 22, 2026

Comparative segment information

Invoicing	2025	2025	2025	2025	2024
EUR million	1-12	1-9	1-6	1-3	1-12
Services	4,146.0	3,049.6	2,044.1	984.6	3,707.1
Products*	66.4	50.6	35.1	20.0	79.6
Invoicing between segments	-11.2	-8.8	-6.5	-4.4	-14.9
Total	4,201.2	3,091.4	2,072.8	1,000.2	3,771.8
*Including dose dispensing Sweden	6.0	6.0	6.0	6.0	21.7
Net sales	2025	2025	2025	2025	2024
EUR million	1-12	1-9	1-6	1-3	1-12
Services	146.5	108.3	73.2	35.3	135.1
Products*	66.3	50.5	35.1	20.0	79.8
Net sales between segments	-11.2	-8.8	-6.5	-4.4	-14.9
Total	201.6	150.0	101.9	50.9	200.0
*Including dose dispensing Sweden	6.0	6.0	6.0	6.0	21.7
Adjusted EBITDA	2025	2025	2025	2025	2024
EUR million	1-12	1-9	1-6	1-3	1-12
Services	37.3	27.3	17.7	8.5	34.6
Products*	5.7	4.0	2.2	1.0	5.5
Group administration and others	-7.9	-6.1	-4.3	-2.0	-6.7
Total	35.1	25.2	15.6	7.5	33.4
*Including dose dispensing Sweden	0.2	0.2	0.2	0.2	0.1
EBITDA	2025	2025	2025	2025	2024
EUR million	1-12	1-9	1-6	1-3	1-12
Services	35.4	26.1	17.4	8.4	34.5
Products*	2.9	1.3	-0.6	1.0	6.0
Group administration and others	-18.0	-12.9	-9.3	-3.5	-13.3
Total	20.3	14.5	7.5	6.0	27.2
*Including dose dispensing Sweden	-2.5	-2.6	-2.6	0.2	1.6
Adjusting items	2025	2025	2025	2025	2024
EUR million	1-12	1-9	1-6	1-3	1-12
Services	1.9	1.2	0.3	0.1	0.1
Products*	2.8	2.8	2.8	0.0	-0.5
Group administration and others	10.1	6.7	5.0	1.5	6.7
Total	14.8	10.7	8.1	1.6	6.2
*Including dose dispensing Sweden	2.8	2.8	2.8	0.0	-1.4
Number of personnel	2025	2025	2025	2025	2024
at the end of the period	1-12	1-9	1-6	1-3	1-12
Services	591	593	604	595	572
Products*	134	133	129	176	172
Group administration and others	76	76	75	74	72
Total	801	801	808	845	816
*Including dose dispensing Sweden	-	-	-	54	49
Average number of personnel, full time equivalents	2025	2025	2025	2025	2024
Services	593	596	587	567	562
Products*	140	142	147	171	176
Group administration and others	80	82	85	95	74
Total	813	819	819	834	812
*Including dose dispensing Sweden	12	16	24	49	48

---

Quarterly invoicing	2025	2025	2025	2025	2024	2024	2024	2024
EUR million	Q4	Q3	Q2	Q1	Q4	Q3	Q2	Q1
Services	1,096.4	1,005.5	1,059.5	984.6	966.6	911.1	936.2	893.1
Products	15.8	15.4	15.2	20.0	21.1	20.6	19.6	18.3
Invoicing between segments	-2.5	-2.3	-2.1	-4.4	-4.2	-4.0	-3.6	-3.1
Total	1,109.8	1,018.6	1,072.6	1,000.2	983.5	927.7	952.2	908.4
Quarterly net sales	2025	2025	2025	2025	2024	2024	2024	2024
---	---	---	---	---	---	---	---	---
EUR million	Q4	Q3	Q2	Q1	Q4	Q3	Q2	Q1
Services	38.2	35.1	37.9	35.3	35.6	31.5	33.7	34.3
Products	15.8	15.4	15.2	20.0	21.4	20.5	19.6	18.3
Net sales between segments	-2.5	-2.3	-2.1	-4.4	-4.2	-4.0	-3.6	-3.1
Total	51.6	48.2	50.9	50.9	52.7	48.1	49.7	49.5
*Including dose dispensing Sweden	0.0	0.0	0.1	6.0	6.2	5.8	5.3	4.4
Quarterly adjusted EBITDA	2025	2025	2025	2025	2024	2024	2024	2024
---	---	---	---	---	---	---	---	---
EUR million	Q4	Q3	Q2	Q1	Q4	Q3	Q2	Q1
Services	10.0	9.6	9.3	8.5	9.5	8.4	7.7	9.0
Products	1.6	1.9	1.1	1.0	1.3	1.8	1.5	0.9
Group administration and others	-1.8	-1.8	-2.3	-2.0	-1.4	-1.8	-1.1	-2.2
Total	9.9	9.6	8.1	7.5	9.4	8.4	8.0	7.7
*Including dose dispensing Sweden	0.0	0.0	0.0	0.2	0.3	0.1	0.2	-0.5
Quarterly EBITDA	2025	2025	2025	2025	2024	2024	2024	2024
---	---	---	---	---	---	---	---	---
EUR million	Q4	Q3	Q2	Q1	Q4	Q3	Q2	Q1
Services	9.3	8.7	9.0	8.4	9.5	8.4	7.7	8.9
Products	1.6	1.9	-1.7	1.0	1.3	0.9	2.9	0.9
Group administration and others	-5.2	-3.6	-5.8	-3.5	-3.8	-4.4	-2.0	-3.1
Total	5.8	7.0	1.6	6.0	7.0	4.9	8.6	6.7
*Including dose dispensing Sweden	0.0	0.0	-2.8	0.2	0.3	0.1	1.7	-0.5
Non-current assets1	2025	2025	2025	2025	2024	2024	2024	2024
---	---	---	---	---	---	---	---	---
EUR million	31 Dec	30 Sep	30 Jun	31 Mar	31 Dec	30 Sep	30 Jun	31 Mar
Services	72.2	72.2	73.1	75.5	61.9	59.3	60.2	61.0
Products	6.6	6.7	6.9	7.2	18.5	16.1	16.6	16.8
Group administration and others	207.4	227.9	228.9	231.6	232.4	252.6	256.4	258.2
Total	286.2	306.7	308.9	314.3	312.8	328.0	333.2	336.0

1 Non-current assets exclude financial instruments and deferred tax assets.

Quarterly investments	2025	2025	2025	2025	2024	2024	2024	2024
EUR million	Q4	Q3	Q2	Q1	Q4	Q3	Q2	Q1
Services	1.4	0.8	0.5	0.2	1.0	0.3	0.3	0.4
Products	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0
Group administration and others	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0
Total	1.6	0.8	0.5	0.3	1.7	0.3	0.4	0.4
Depreciation, amortisation and impairments, EUR million	2025 1-12	2025 1-9	2025 1-6	2025 1-3	2024 1-12	2024 1-9	2024 1-6	2024 1-3
---	---	---	---	---	---	---	---	---
Services	10.2	7.6	5.1	2.5	10.1	7.6	5.1	2.6
Products	7.4	7.0	6.6	6.1	1.5	1.1	0.7	0.4
Group administration and others	0.2	0.1	0.1	0.0	2.0	1.9	0.1	0.0
Total	17.7	14.7	11.8	8.7	13.6	10.6	5.9	3.0